Keywords: verona, rpl554, enters, toxicology, study, uk-based, pharma

Verona's RPL554 enters toxicology study

Article | 15 October 2007

UK-based Verona Pharma says that its novel anti-asthmatic compound, RPL554, is now entering a 28-day experimental inhalation toxicology study to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Drug Discovery

GlaxoSmithKline

GSK

Go to company listing